Peihua Luo

14PUBLICATIONS
9CO-AUTHORS
Haematological tumoursMolecular targetsSpeciation and extinctionCheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 10, 2026
Liver-originated selective autophagy of BTD by alectinib underlies concurrent hepatotoxicity and dermatotoxicity.

|Oct 20, 2025
Entrectinib binds to HMGB1 and activates cardiomyocyte autophagy by inhibiting OTUD5-MTORC1 signaling to induce cardiotoxicity.

Zizheng Gao, Jiaqi Zhang, Huangxi Fu

|Mar 27, 2025
The inducible role of autophagy in cell death: emerging evidence and future perspectives.

Xiangliang Huang, Hao Yan, Zhifei Xu

|Jan 21, 2025
Disturbing Cholesterol/Sphingolipid Metabolism by Squalene Epoxidase Arises Crizotinib Hepatotoxicity.

Hao Yan, Xiangliang Huang, Yourong Zhou

|Oct 08, 2024
Development and safety of investigational and approved drugs targeting the RAS function regulation in RAS mutant cancers.

Jinjin Li, Wentong Wu, Jiajia Chen

|Sep 30, 2024
Schisandrin C prevents regorafenib-induced cardiotoxicity by recovering EPHA2 expression in cardiomyocytes.

Bo Xu, Ning Liu, Taicheng Zhou

Pageof 3

Frequent Collaborators

8 joint publications

Zhifei Xu

6 joint publications

Hao Yan

5 joint publications

Bo Yang

5 joint publications

Qiaojun He